Company profile
Cognetivity Neurosciences Ltd.
OTC: CGNSF · Healthcare · Medical - Healthcare Information Services
Canadian filerHQ Vancouver, BCReports USD
#1100 of 1,418 Healthcare companies by revenue
EA Score
——FH —DQ —GM —SS 42
v0.1 · 5/100 weight · pillars only
↑ workforce scale, disclosure history · ↓ operating margin, net margin
Methodology →Revenue TTM
$73.4k
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
-$5.7M
Employees
2,500
as of 2026-08-30
Market cap
$9.0k
as of 2026-08-30
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$34.7k45.4k CAD2022
Net income-$5.7M-7.4M CAD2022
Operating income-$4.8M-6.3M CAD2022
Total assets$2.1M2.8M CAD2022
Liabilities$9.5M12.7M CAD2022
Equity-$7.4M-9.9M CAD2022
Revenue trend
FY2016 – FY2022 · USD
FY16
FY17
FY18
FY19
FY20
FY21
FY22
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Cognetivity Neurosciences Ltd.’s revenue?
Cognetivity Neurosciences Ltd. booked $34.7k in FY2022 revenue — among the slowest-growing Healthcare companies we track, at a -16386.3% net margin.
Peers · Healthcare
Lyell Immunopharma, Inc.31DNanoLogix, Inc.——Mountain Valley MD Holdings Inc.——CuraScientific Corp——Impact BioMedical Inc.32DenVVeno Medical Corporation40DKey facts
CEOSina Habibi
SectorHealthcare
IndustryMedical - Healthcare Information Services
HeadquartersVancouver, BC
ExchangeOTC: CGNSF
Employees2,500
IPO date2021-01-08
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.